Literature DB >> 21181366

Proliferation characteristics of CD133+ cell population in colorectal cancer.

Dongdong Yu1, Yonghong Zhang, You Zou, Jichao Qin, Xiaolan Li, Hui Xiao, Deding Tao, Junbo Hu, Jianping Gong.   

Abstract

In this study, CD133+ subpopulations were isolated from 41 primary colorectal cancer tissues, the proliferation and cell cycle distribution of the cells were examined without in vitro expansion, and then compared to those of cell lines. The detection of CD133 in colorectal cancer tissues, isolation of CD133+ and CD133- epithelial subpopulations, Ki-67/DNA multiparameter assay and cell volume analysis were flow cytometrically conducted. The results showed that Ki-67 expression was correlated with CD133 level in primary cancer tissues, while cell cycle G2/M phase distribution or clinicopathological characteristics was not. In addition, the CD133+ cells showed larger cell volume and higher Ki-67 expression as compared with CD133- cells. But there was no statistically significant difference in G(2)/M phase distribution between the two subpopulations. Our results demonstrated that the CD133+ subpopulation in colorectal cancer tissue contained more actively cycling and proliferating cells, which was not correlated to clinicopathological factors but might contribute to tumor progression and poor clinical outcome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21181366     DOI: 10.1007/s11596-010-0652-9

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  30 in total

1.  CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.

Authors:  L Kobari; M C Giarratana; F Pflumio; B Izac; L Coulombel; L Douay
Journal:  J Hematother Stem Cell Res       Date:  2001-04

2.  Analysis of DNA ploidy, cell cycle and Ki67 antigen in nasopharyngeal carcinoma by flow cytometry.

Authors:  Xiaoyan Shi; Xianglin Yuan; Deding Tao; Jianping Gong; Guoqing Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning.

Authors:  S Miraglia; W Godfrey; A H Yin; K Atkins; R Warnke; J T Holden; R A Bray; E K Waller; D W Buck
Journal:  Blood       Date:  1997-12-15       Impact factor: 22.113

4.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

5.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Authors:  Stephanie Ma; Kwok-Wah Chan; Liang Hu; Terence Kin-Wah Lee; Jana Yim-Hung Wo; Irene Oi-Lin Ng; Bo-Jian Zheng; Xin-Yuan Guan
Journal:  Gastroenterology       Date:  2007-04-15       Impact factor: 22.682

Review 6.  Cancer stem cells in solid tumors.

Authors:  Laurie E Ailles; Irving L Weissman
Journal:  Curr Opin Biotechnol       Date:  2007-10       Impact factor: 9.740

7.  Are progenitor cells pre-programmed for sequential cell cycles not requiring cyclins D and E and activation of Cdk2?

Authors:  D-X Xie; J Yao; P Zhang; X-L Li; Y-D Feng; J-H Wu; D-D Tao; J-B Hu; J-P Gong
Journal:  Cell Prolif       Date:  2008-04       Impact factor: 6.831

8.  Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

Authors:  Patrick C Hermann; Stephan L Huber; Tanja Herrler; Alexandra Aicher; Joachim W Ellwart; Markus Guba; Christiane J Bruns; Christopher Heeschen
Journal:  Cell Stem Cell       Date:  2007-09-13       Impact factor: 24.633

9.  Phenotypic characterization of human colorectal cancer stem cells.

Authors:  Piero Dalerba; Scott J Dylla; In-Kyung Park; Rui Liu; Xinhao Wang; Robert W Cho; Timothy Hoey; Austin Gurney; Emina H Huang; Diane M Simeone; Andrew A Shelton; Giorgio Parmiani; Chiara Castelli; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-04       Impact factor: 11.205

10.  CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.

Authors:  Sergey V Shmelkov; Jason M Butler; Andrea T Hooper; Adilia Hormigo; Jared Kushner; Till Milde; Ryan St Clair; Muhamed Baljevic; Ian White; David K Jin; Amy Chadburn; Andrew J Murphy; David M Valenzuela; Nicholas W Gale; Gavin Thurston; George D Yancopoulos; Michael D'Angelica; Nancy Kemeny; David Lyden; Shahin Rafii
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.